Drug Research
Biden Medicare Benefits Due To Alzheimers Medicine Shift
Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden celebrated success on September 27th by claiming that expenditures for tens of millions of Americans enrolled in the Medicare...
Clinical Trials
Testing Expert: Omicron Virus Likely To Secure Against Flu
Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns in the fall. Interestingly, according to a top testing specialist, if you recently had a case of COVID, you...
Drug Research
Australia Sponsors Future COVID-19 Vaccination Research
In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants emerge, the Australian government is funding a new study on COVID-19 vaccinations and infection.
The new PROPHECY study, directed by...
Drug Research
FDA And NIH Working Together To Discover More About ALS
The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for amyotrophic lateral sclerosis (ALS) and similar rare neurodegenerative conditions, has been initiated by the US Food and Drug Administration...
News
Naturopathic Solutions to Keep Your Immune System Healthy
You know you should get a flu shot every year to help keep your immune system strong, but what else can you do to help protect yourself? Naturopathic solutions can be a great way to boost your immune system...
News
COVID Increases Long-Term Brain Injury Concern- US Study
According to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a variety of brain damage a year later than those who had never had the coronavirus. This result may have...
News
New Global Survey Reveals Shift in Clinical Trial Priorities; Payment Efficiencies Emerge as Leading Concern for Sponsors, CROs and Sites
Greenphire, the global leader in financial lifecycle management for clinical trials, announced results from its 2022 annual market trends survey which examined top challenges and opportunities for sponsors, CROs, and sites across the globe. While survey respondents represented a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















